Historical salary details - Ms. Bihua Chen, Independent Director, Biomea Fusion Inc
Ms. Bihua Chen is the Independent Director of Biomea Fusion Inc. They also hold 1 other positions in and Helix Acquisition Corp. II - Ordinary Shares - Class A.
Ms. Bihua Chen
Independent Director
-
Gross Remuneration
-
Current Company
Biomea Fusion Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Biomea Fusion Inc | Independent Director | - | - |
| 2024 | Helix Acquisition Corp. II - Ordinary Shares - Class A | Chairperson of the Board and Chief Executive Offic | - | - |
| 2023 | Erasca Inc | Independent Director | 148.2 K | -26.4 % |
| 2022 | Biomea Fusion Inc | Independent Director | 224.9 K | -42.9 % |
| 2022 | Erasca Inc | Independent Director | 201.4 K | -71.2 % |
| 2022 | Helix Acquisition Corp. II - Ordinary Shares - Class A | Chairperson of the Board and Chief Executive Offic | - | - |
| 2021 | Erasca Inc | Independent Director | 700.0 K | - |
| 2021 | Biomea Fusion Inc | Independent Director | 393.7 K | - |
| 2020 | C4 Therapeutics Inc | Independent Director | 18.8 K | -25.0 % |
| 2020 | Biomea Fusion Inc | Director | - | - |
| 2020 | Erasca Inc | Independent Director | - | - |
| 2019 | C4 Therapeutics Inc | Independent Director | 25 K | - |
| 2019 | Atea Pharmaceuticals Inc | Director | - | - |
| 2018 | Kezar Life Sciences Inc | Independent Director | - | - |
| 2017 | Apellis Pharmaceuticals Inc | Director | - | - |
| 2017 | Kezar Life Sciences Inc | Independent Director | - | - |
| 2016 | Apellis Pharmaceuticals Inc | Director | - | - |